China approves Lilly's Foundayo, the country's first GLP-1 weight-loss pill
_Image credit: The Independent_
China's medicines regulator has approved Eli Lilly's orforglipron (sold as Foundayo), the first GLP-1 weight-loss pill cleared there; until now only injections were approved for weight management in China. Novo Nordisk's application for its Wegovy pill in China is still under review, and Lilly has not said what Foundayo will cost there.
Source: The Independent (12 Nov 2026). Image: The Independent.